image
Healthcare - Biotechnology - NASDAQ - US
$ 3.11
1.68 %
$ 2.21 M
Market Cap
-0.01
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
27.54%
Net Income Estimate
19.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Aptevo Therapeutics Inc.
image
APVO has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart APVO

image
$45.0m$45.0m$40.0m$40.0m$35.0m$35.0m$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart APVO

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart APVO

image
$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029